• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Sonia T. Oskouei, PharmD: Biosimilars and Misinformation

Video

Sonia T. Oskouei, PharmD, vice president of innovation and solution development at Premier Inc, discusses biosimilars and misinformation.

Transcript

So, it is hard to manage all of the information that’s out there. Understandably, there’s a lot of different data sources and sites where you can get information, so to manage it all alone is a challenge. But there’s different information out there that talks about aspects of biosimilars, from interchangeability to extrapolation. When it’s out there, it could cause a misunderstanding about biosimilars, whether it’s intentional or not. So that’s, again, the need for education from a patient and provider level to help clarify any of those aspects with biosimilars.

Related Videos
Jeffrey Casberg, RPh, MS.
Adam Colborn, JD.
Legal scale weighs profit as greater than medical treatment
Ha Kung Wong, JD.
Ha Kung Wong, JD
Cencora's Corey Ford
Brian Biehn
Chelsee Jensen, PharmD, BCPS
Ryan Haumschild, PharmD, MS, MBA
Related Content
© 2024 MJH Life Sciences

All rights reserved.